EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research
- PMID: 18214670
- PMCID: PMC2259255
- DOI: 10.1007/s10484-007-9047-5
EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research
Abstract
Electroencephalographic (EEG) biofeedback has been employed in substance use disorder (SUD) over the last three decades. The SUD is a complex series of disorders with frequent comorbidities and EEG abnormalities of several types. EEG biofeedback has been employed in conjunction with other therapies and may be useful in enhancing certain outcomes of therapy. Based on published clinical studies and employing efficacy criteria adapted by the Association for Applied Psychophysiology and Biofeedback and the International Society for Neurofeedback and Research, alpha theta training-either alone for alcoholism or in combination with beta training for stimulant and mixed substance abuse and combined with residential treatment programs, is probably efficacious. Considerations of further research design taking these factors into account are discussed and descriptions of contemporary research are given.
Similar articles
-
Electroencephalographic biofeedback in the treatment of attention-deficit/hyperactivity disorder.Appl Psychophysiol Biofeedback. 2005 Jun;30(2):95-114. doi: 10.1007/s10484-005-4305-x. Appl Psychophysiol Biofeedback. 2005. PMID: 16013783 Review.
-
Electroencephalographic biofeedback (neurotherapy) as a treatment for attention deficit hyperactivity disorder: rationale and empirical foundation.Child Adolesc Psychiatr Clin N Am. 2005 Jan;14(1):55-82, vi. doi: 10.1016/j.chc.2004.07.004. Child Adolesc Psychiatr Clin N Am. 2005. PMID: 15564052 Review.
-
The treatment of addictive disorders by brain wave biofeedback: a review and suggestions for future research.Clin Electroencephalogr. 2000 Jan;31(1):13-22. doi: 10.1177/155005940003100107. Clin Electroencephalogr. 2000. PMID: 10638348 Review. No abstract available.
-
Treatment of attention deficit hyperactivity disorder with neurotherapy.Clin Electroencephalogr. 2000 Jan;31(1):30-7. doi: 10.1177/155005940003100109. Clin Electroencephalogr. 2000. PMID: 10638350 Review.
-
The state of EEG biofeedback therapy (EEG operant conditioning) in 2000: an editor's opinion.Clin Electroencephalogr. 2000 Jan;31(1):V-VII. Clin Electroencephalogr. 2000. PMID: 10638345 No abstract available.
Cited by
-
Efficacy of Biofeedback for Medical Conditions: an Evidence Map.J Gen Intern Med. 2019 Dec;34(12):2883-2893. doi: 10.1007/s11606-019-05215-z. Epub 2019 Aug 14. J Gen Intern Med. 2019. PMID: 31414354 Free PMC article. Review.
-
Does combined training of biofeedback and neurofeedback affect smoking status, behavior, and longitudinal brain plasticity?Front Behav Neurosci. 2023 Jan 27;17:1096122. doi: 10.3389/fnbeh.2023.1096122. eCollection 2023. Front Behav Neurosci. 2023. PMID: 36778131 Free PMC article.
-
Predicting vasovagal reactions to needles from video data using 2D-CNN with GRU and LSTM.PLoS One. 2025 Jan 24;20(1):e0314038. doi: 10.1371/journal.pone.0314038. eCollection 2025. PLoS One. 2025. PMID: 39854293 Free PMC article.
-
Neurofeedback Effects on Evoked and Induced EEG Gamma Band Reactivity to Drug-related Cues in Cocaine Addiction.J Neurother. 2010 Jul;14(3):195-216. doi: 10.1080/10874208.2010.501498. J Neurother. 2010. PMID: 20976131 Free PMC article.
-
Neurofeedback for opioid dependent patients in an outpatient setting: a pilot feasibility study.Subst Abuse Treat Prev Policy. 2022 Apr 15;17(1):28. doi: 10.1186/s13011-022-00458-2. Subst Abuse Treat Prev Policy. 2022. PMID: 35428348 Free PMC article. Clinical Trial.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10333992', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10333992/'}]}
- Alper, K. R. (1999). The EEG and cocaine sensitization. Journal of Neuropsychiatry and Clinical Neuroscience, 11, 209–221. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '2100807', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2100807/'}]}
- Alper, K. R., Chabot, R. J., Kim, A. H., Prichep, L. S, & John, E. R. (1990). Quantitative EEG correlates of crack cocaine dependence. Psychiatry Research, 35, 95–106. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9608571', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9608571/'}]}
- Alper, K. R., Prichep, L. S., Kowalik, S., Rosenthal, M. S, & John, E. R. (1998). Persistent QEEG abnormality in crack cocaine users at 6 months of drug abstinence. Neuropsychopharmacology, 19, 1–9. - PubMed
-
- American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.) [DSM-IV], Text revised. Washington, DC.
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16337872', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16337872/'}]}
- Barnea, A., Rassis, A., & Zaidel, E. (2005). Effect of neurofeedback on hemispheric word recognition. Brain & Cognition, 59, 314–321. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical